NEXFLEX TOTAL KNEE SYSTEM

K991882 · Nexmed, Inc. · JWH · Dec 8, 1999 · Orthopedic

Device Facts

Record IDK991882
Device NameNEXFLEX TOTAL KNEE SYSTEM
ApplicantNexmed, Inc.
Product CodeJWH · Orthopedic
Decision DateDec 8, 1999
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3560
Device ClassClass 2
AttributesTherapeutic

Intended Use

The NexFlex Total Knee System is indicated for: - Painful, disabling joint disease resulting from rheumatoid arthritis, post-traumatic arthritis, osteoarthritis, or degenerative arthritis - Failed osteotomies, unicompartmental replacement, or total knee replacement - Post-traumatic loss of knee joint configuration and function - Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability The NexFlex Total Knee System is intended for cemented use only.

Device Story

NexFlex Total Knee System is a semi-constrained total knee prosthesis; components include femoral components, tibial base components, tibial inserts, all-polyethylene tibial components, cancellous bone screws, tibial screw hole caps, tibial stem extensions, and patellar components. System components are designed for exclusive use within the NexFlex system. Device is intended for cemented use only. Surgeons implant the device to replace damaged knee joints, restoring joint configuration and function. Benefits include pain relief and improved mobility for patients with degenerative or post-traumatic joint disease.

Clinical Evidence

Bench testing only. Mechanical testing was performed in accordance with the Draft Guidance for the Preparation of Premarket Notifications (510(k)s) for Cemented, Semi-Constrained Total Knee Prostheses to verify the system's capability to withstand in vivo loading.

Technological Characteristics

Materials: Cobalt-chromium alloy (femoral components), titanium (Ti-6Al-4V) alloy (tibial base, screws, caps, stems, patellar backing), ultra-high molecular weight polyethylene (inserts, all-polyethylene tibial components, patellar components). Features: Commercially pure titanium plasma sprayed surfaces available on femoral and tibial components. Design: Semi-constrained, cemented, modular system. Mechanical engagement for stem extensions and tibial inserts.

Indications for Use

Indicated for patients with painful, disabling joint disease (rheumatoid, post-traumatic, osteoarthritis, degenerative), failed prior knee surgeries (osteotomies, unicompartmental, or total knee replacement), post-traumatic loss of joint function, or moderate varus/valgus/flexion deformity with stable ligamentous structures.

Regulatory Classification

Identification

A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ DEC - 8 1999 Image /page/0/Picture/1 description: The image shows the logo and name of a company called "Nexmed, Inc." along with the product name "NexFlex Total Knee System" and the text "Premarket Notification". The logo is a stylized letter "n" inside a circle. The text is in a serif font and is black in color. The image is likely from a document or advertisement for the company's knee replacement product. # 510(k) Summary 510(k) Number #### Manufacturer Identification | Submitted By: | Nexmed, Inc.<br>42-160 State Street<br>Palm Desert, CA 92211<br>phone: (760) 779-8250<br>fax: (760) 776-5527 | |------------------------|--------------------------------------------------------------------------------------------------------------| | Contact Person: | Jason Blain<br>Manager of Product Development | | Date Summary Prepared: | May 21, 1999 | | Device Identification | | | Proprietary Name: | NexFlex Total Knee System | | Common Name: | Semi-constrained total knee prosthesis | | Classification: | 21 CFR 888.3560: Prosthesis, Knee, Patellofemorotibial,<br>Semi-constrained, Cemented, Polymer/Metal/Polymer | #### Device Description The NexFlex Total Knee System consists of femoral components, tibial base components, tibial inserts, all-polyethylene tibial components, cancellous bone screws, a tibial screw hole cap, tibial stem extensions, and patellar components. The components of this system are designed to be used together and cannot be used as part of another system, nor can components of another system be incorporated into use with the NexFlex Total Knee System. NexFlex femoral components are manufactured from cobalt-chromium alloy and are available in a range of sizes and in left and right orientations. They are available with or without a commercially pure titanium plasma sprayed inner surface. Tibial base components are manufactured from titanium (Ti-6Al-4V) alloy and are available in a range of sizes. They are available with or without a commercially pure titanium plasma sprayed distal surface. Tibial inserts are manufactured from ultra-high molecular weight polyethylene and are available in a range of sizes to match the tibial base components. The distal side of the tibial inserts has geometry to allow a mechanical lock to the tibial base components of {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows a close-up of text, with the words "Premark" and "NexFlex" clearly visible. The text appears to be part of a larger document or label, possibly related to a product or company name. The font is a serif typeface, and the text is printed in black ink on a white background. corresponding size. The proximal side of the tibial inserts has geometry that allows articulation with the femoral components. Tibial inserts are available with two different proximal geometries, allowing for different amounts of constraint and contact area with the femoral components. A number of thicknesses of inserts are offered. All-polyethylene tibial components are manufactured from ultra-high molecular weight polyethylene and are available in a range of sizes and thicknesses. These components have distal geometry similar to the tibial base components and proximal geometry similar to the tibial inserts. Cancellous bone screws are manufactured from titanium (Ti-6Al-4V) alloy and are available in a range of lengths. The screws are designed to go through the tibial base component to secure it to the proximal tibia. Tibial screw hole caps are manufactured from titanium (Ti-6Al-4V) alloy. They are designed to thread into the tibial base components to cover the screw holes when a cancellous bone screw is not used. Tibial stem extensions are manufactured from titanium (Ti-6A1-4V) alloy and are available in a range of diameters and lengths. The stems are designed to mate with the tibial base components by means of a mechanical engagement. Patellar components are manufactured from either ultra-high molecular weight polyethylene or a combination of ultra-high molecular weight polyethylene and titanium (Ti-6Al-4V) alloy. They are designed with posterior geometry that allows articulation with the femoral components. Patellar components with titanium backing have a commercially pure titanium plasma spraved anterior surface. ## Intended Use of the Device The NexFlex Total Knee System is indicated for: - Painful, disabling joint disease resulting from rheumatoid arthritis, post-traumatic . arthritis, osteoarthritis, or degenerative arthritis - . Failed osteotomies, unicompartmental replacement, or total knee replacement - Post-traumatic loss of knee joint configuration and function . - Moderate varus, valgus, or flexion deformity in which the ligamentous structures can . be returned to adequate function and stability The NexFlex Total Knee System is intended for cemented use only. # Substantial Equivalence The NexFlex Total Knee System is substantially equivalent to the following knee systems: Miller/Gallante Total Knee System (Zimmer, Inc.), AGC Total Knee System (Biomet, Inc.), AMK Total Knee System (DePuy, a Johnson Company), Series 7000 Total Knee System (Stryker/Osteonics). The NexFlex Total Knee System is {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows the word "NexFlex" in a bold, italicized font. Above the word "NexFlex" is the word "Prema" in a smaller, non-bolded font. The image is black and white and the text is slightly blurry. similar to each of the listed predicate devices in one or more of the following areas: design, function, materials used, and indications for use. ### Non-Clinical Performance Data Mechanical testing of the NexFlex Total Knee System was performed in accordance with the recommended testing listed in the Draft Guidance for the Preparation of Premarket Notifications (510(k)s) for Cemented, Semi-Constrained Total Knee Prostheses. Testing indicated that the system is capable of withstanding in vivo loading without failure. {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, representing medicine and healing. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus symbol. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 DEC - 8 1999 Mr. Jason Blain Manager of Product Development Nexmed Incorporated 42-160 State Street Palm Dessert. California 92211 Re: K991882 Trade Name: NexFlex Total Knee System Regulatory Class: II Product Codes: JHW Dated: May 28, 1999 Received: June 2, 1999 Dear Mr. Blain: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {4}------------------------------------------------ Page 2 - Mr. Blain This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits vour device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". An Sincerely yours, James E. Dillard III Acting Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ Image /page/5/Picture/0 description: The image contains a black circle with a white letter 'n' inside of it. To the right of the circle is a capital letter 'N'. The letter 'N' is slightly larger than the letter 'n' inside of the circle. The image is simple and contains only these two characters. ### Indications for Use 510(k) Number: K991882 Device Name: NexFlex Total Knee System Indications for Use: - Painful, disabling joint disease resulting from rheumatoid arthritis, post-traumatic . arthritis, osteoarthritis, or degenerative arthritis - Failed osteotomies, unicompartmental replacement, or total knee replacement ● - Post-traumatic loss of knee joint configuration and function . - Moderate varus, valgus, or flexion deformity in which the ligamentous structures can ◆ be returned to adequate function and stability The NexFlex Total Knee System is intended for cemented use only. thut Clurde (Division Sign-Off) (Division Sign Division of General Restorative Devices K99188 510(k) Number Prescription Use X (Per 21 CFR 801.109) Over-the-Counter Use_
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%